We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.82%
2 Technology 2.79%
3 Financials 2.26%
4 Consumer Discretionary 1.92%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COP icon
201
PUT
ConocoPhillips
COP
$151B
$263M 0.07%
2,927,748
+524,000
+22% +$54M
DE icon
202
PUT
Deere & Co
DE
$167B
$260M 0.07%
869,100
-286,300
-25% -$105M
TWTR
203
CALL
DELISTED
Twitter, Inc.
TWTR
$260M 0.07%
6,950,600
+313,300
+5% +$13.4M
ORCL icon
204
CALL
Oracle
ORCL
$419B
$260M 0.07%
3,719,400
+562,000
+18% +$41.1M
AMT icon
205
American Tower
AMT
$79B
$260M 0.07%
1,015,902
+975,170
+2,394% +$245M
MRNA icon
206
PUT
Moderna
MRNA
$24.2B
$260M 0.07%
1,817,300
-1,465,600
-45% -$209M
ENPH icon
207
PUT
Enphase Energy
ENPH
$5.59B
$260M 0.07%
1,329,600
+367,200
+38% +$66.4M
BAC icon
208
Bank of America
BAC
$448B
$259M 0.07%
8,317,956
+504,718
+6% +$18.2M
EFA icon
209
CALL
iShares MSCI EAFE ETF
EFA
$79.9B
$258M 0.07%
4,135,100
+445,900
+12% +$30.3M
PEP icon
210
PUT
PepsiCo
PEP
$189B
$258M 0.07%
1,549,400
-212,200
-12% -$35.7M
MDLZ icon
211
Mondelez International
MDLZ
$78.9B
$258M 0.07%
4,154,314
+2,243,066
+117% +$142M
MS icon
212
CALL
Morgan Stanley
MS
$338B
$258M 0.07%
3,385,800
+102,800
+3% +$8.42M
XBI icon
213
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$257M 0.07%
3,462,100
+302,300
+10% +$22.7M
USO icon
214
PUT
United States Oil Fund
USO
$1.8B
$256M 0.07%
3,185,860
+89,076
+3% +$7.22M
T icon
215
CALL
AT&T
T
$168B
$256M 0.07%
12,199,700
-5,209,311
-30% -$104M
FANG icon
216
CALL
Diamondback Energy
FANG
$56.5B
$256M 0.07%
2,109,800
+225,700
+12% +$30.9M
ABNB icon
217
PUT
Airbnb
ABNB
$111B
$252M 0.06%
2,833,000
+45,900
+2% +$5.97M
GME icon
218
CALL
GameStop
GME
$8.44B
$252M 0.06%
8,246,400
-6,194,800
-43% -$197M
BMY icon
219
CALL
Bristol-Myers Squibb
BMY
$130B
$252M 0.06%
3,274,200
-58,900
-2% -$4.49M
KRE icon
220
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.61B
$252M 0.06%
4,336,900
+1,046,800
+32% +$65.4M
UNP icon
221
CALL
Union Pacific
UNP
$174B
$251M 0.06%
1,176,300
+71,200
+6% +$16.2M
SNOW icon
222
PUT
Snowflake
SNOW
$116B
$250M 0.06%
1,796,800
+112,200
+7% +$17.8M
ROKU icon
223
CALL
Roku
ROKU
$22.4B
$249M 0.06%
3,035,100
+312,000
+11% +$30.2M
IQV icon
224
IQVIA
IQV
$40.1B
$249M 0.06%
1,145,827
+395,941
+53% +$86M
MDB icon
225
CALL
MongoDB
MDB
$35.3B
$246M 0.06%
946,600
+349,200
+58% +$109M

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.